XML 19 R4.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Product and service revenue $ 2,620,845 $ 2,325,769 $ 7,614,250 $ 5,488,946
Research and development contract revenue 1,562,719 778,017 2,347,943 1,985,991
Licensed technology revenue 163,125   326,250  
Total revenue 4,346,689 3,103,786 10,288,443 7,474,937
Cost of product and service revenue 4,931,170 4,542,373 11,621,623 7,830,226
Cost of research and development contract revenue 2,473,516 1,679,372 3,810,596 3,560,886
Research and development expense 1,106,248 4,381,814 2,168,974 9,868,531
Selling, general and administrative expenses 3,882,917 10,540,814 7,444,515 14,398,531
Amortization of intangible assets 588,473 566,880 1,169,962 1,129,055
Operating loss (8,635,635) (18,607,467) (15,927,227) (29,312,292)
Interest and other income and net realized losses from available-for-sale securities 87,224 268,622 121,122 610,661
Change in fair value of warrant liability 1,790,520   1,790,520  
Change in fair value of auction rate securities repurchase agreement   (2,469,113)   (3,135,032)
Net trading gain   2,469,113   3,135,032
Interest and other expense and foreign currency gain (loss) 5,223 (177,110) 19,717 (373,074)
Net loss $ (6,752,668) $ (18,515,955) $ (13,995,868) $ (29,074,705)
Loss per share:        
Basic and diluted (in dollars per share) $ (0.41) $ (1.41) $ (0.95) $ (2.22)
Weighted average number of common shares outstanding (in shares) 16,320,235 13,116,175 14,781,215 13,080,315